This journal presents incisive reviews by international experts, on all aspects of pharmacology, including drug discovery and development. Coverage spans such key subjects as epigenetics and epigenomics, chemoinformatics, rational drug design and target discovery, drug delivery and biomaterial, pharmacogenomics and molecular targets and biomarkers, chemical/drug/molecular toxicology, absorption, distribution, metabolism and elimination (ADME), pharmacokinetics and pharmacodynamics, modeling & simulation and pharmacometrics, and related topics in disease, including neurology and the central nervous system, cardiovascular disease, metabolic diseases, cancer and others.

  • Presents cutting-edge reviews on subjects pertinent to all aspects of pharmacology
  • Offers incisive, insightful, and balanced contributions by international leading experts
  • Benefits a wide readership of scientists and translational investigators in academia and in industry

Journal information

Editor-in-Chief
  • Ah-Ng Tony Kong
Publishing model
Hybrid. Open Access options available

Journal metrics

54,948 (2019)
Downloads

Latest articles

This journal has 16 open access articles

Subscribe

eJournal
$99.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles
  • Downloadable in PDF format
  • Subscription expires 12/31/2020

About this journal

Electronic ISSN
2198-641X
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Dimensions
  4. EBSCO Discovery Service
  5. EMBASE
  6. Google Scholar
  7. Institute of Scientific and Technical Information of China
  8. Japanese Science and Technology Agency (JST)
  9. Meta
  10. Naver
  11. OCLC WorldCat Discovery Service
  12. ProQuest-ExLibris Primo
  13. ProQuest-ExLibris Summon
  14. Reaxys
  15. SCImago
  16. SCOPUS
  17. TD Net Discovery Service
  18. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG